Hemophilia is a rare bleeding disorder characterized by low levels of proteins called “clotting factors.” Hemophilia is an inherited blood disorder in which your blood does not clot properly.

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.

The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 ...

Frequent blood donors may be getting more than a warm, fuzzy feeling from their altruism, as giving blood may also enhance your ability to produce healthy blood cells, potentially reducing the ...

Discover top medications for 'treating Hemophilia'? This page compiles essential information on generic and brand-name drugs specifically used for Hemophilia treatment.Here, you can explore ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved fitusiran (Qfitlia, Sanofi) for routine prophylaxis for prevention or reduction in bleeding ...

creating potentially life-threatening risks from otherwise normal situations experienced by those without hemophilia. The ...

PARIS, France I March 28, 2025 I The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for ...